| Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell Transplant (NCT03821519) | A.O. Ospedale Papa Giovanni XXIII | 2019-01-13 |
| Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors (NCT02856503) | Eli Avisar, MD | 2019-01-13 |
| Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients (NCT04093336) | Shanghai East Hospital | 2019-01-13 |
| A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma (NCT03710915) | HitGen Inc. | 2019-01-12 |
| Infasurf®(Calfactant) Aerosol for Infants With Bronchiolitis-AERO-04 (NCT03748173) | ONY | 2019-01-12 |
| Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers (NCT05125575) | Joint Stock Company "Farmak" | 2019-01-11 |
| Teneligliptin and Atorvastatin DDI Study (NCT03769870) | Handok Inc. | 2019-01-11 |
| BTK Inhibitor DTRMWXHS-12 in Mantle Cell Lymphoma (NCT03836768) | Zhejiang DTRM Biopharma | 2019-01-11 |
| A Study of Apalutamide Administered Orally as Whole Tablets and as a Mixture in Applesauce in Healthy Participants (NCT03802682) | Janssen Research & Development, LLC | 2019-01-11 |
| Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate (NCT03582475) | Jonsson Comprehensive Cancer Center | 2019-01-11 |
| Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD) (NCT03548051) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-01-11 |
| A Clinical Trial to Evaluate the Safety of RP-L102 in Pediatric Subjects With Fanconi Anemia Subtype A (NCT03814408) | Rocket Pharmaceuticals Inc. | 2019-01-11 |
| A Study Investigating the Absolute Oral Bioavailability of Balovaptan After Single and Multiple Daily Oral Doses of Balovaptan in Healthy Volunteers (NCT03764449) | Hoffmann-La Roche | 2019-01-10 |
| Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants (NCT03796182) | Pfizer | 2019-01-10 |
| A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release Capsules (NCT03801148) | Takeda | 2019-01-10 |
| Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors (NCT03637803) | 4D pharma plc | 2019-01-10 |
| A Phase 1 Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI188 in Advanced Malignancies (NCT03717103) | Innovent Biologics (Suzhou) Co. Ltd. | 2019-01-10 |
| A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX (NCT03450018) | British Columbia Cancer Agency | 2019-01-10 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 730357 in the Blood (NCT03782987) | Boehringer Ingelheim | 2019-01-10 |
| Trial of Tauroursodeoxycholic Acid (TUDCA) in Asthma (NCT03878654) | University of Vermont | 2019-01-10 |
| Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas (NCT03953131) | M.D. Anderson Cancer Center | 2019-01-10 |
| A Study to Investigate the Bioequivalence of Two Different Forms of Entrectinib (Forms A and C) Under Fasted Conditions in Healthy Subjects (NCT03796013) | Genentech, Inc. | 2019-01-10 |
| Bioequivalence Study of Sotalol, Tablets, 160 mg (Pharmtechnology LLC, Belarus), and Sotalex ®, Tablets, 160 mg (Bristol-Myers Squibb GmbH & Co. KGaA, Germany), in Healthy Volunteers Under Fasting Conditions (NCT03799536) | Pharmtechnology LLC | 2019-01-09 |
| Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma (NCT03331341) | University of Washington | 2019-01-09 |
| Spironolactone Therapy In Young Women With NASH (NCT03576755) | University of California, San Francisco | 2019-01-09 |
| A Study to Investigate the Relative Bioavailability of Entrectinib Capsule Formulations F1 and F06 Under Fed Conditions in Healthy Participants (NCT03796260) | Genentech, Inc. | 2019-01-09 |
| A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB) (NCT03752905) | Phoenix Tissue Repair, Inc. | 2019-01-09 |
| Group B Streptococcus Vaccine in Healthy Females (NCT03807245) | Minervax ApS | 2019-01-09 |
| A Clinical Study of Cobimetinib Administered in Combination With Niraparib, With or Without Atezolizumab to Patients With Advanced Platinum-sensitive Ovarian Cancer (NCT03695380) | Hoffmann-La Roche | 2019-01-09 |
| A Study Evaluating the Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 (NCT03745625) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2019-01-09 |
| A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants (NCT05927597) | Insmed Incorporated | 2019-01-09 |
| Safety of Lactobacillus Reuteri in Healthy Children Aged 2-24 Months (NCT02460575) | Tulane University School of Medicine | 2019-01-09 |
| Study to Learn More About the Effect of Itraconazole (ITZ) Given Repeatedly by Mouth on the Way How the Study Drug BAY1902607 Given One Time by Mouth Acts in the Human Body of Healthy Male Participants (NCT03789890) | Bayer | 2019-01-08 |
| Safety of TT-00420 (Tinengotinib) Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer (NCT03654547) | TransThera Sciences (Nanjing), Inc. | 2019-01-08 |
| A SAD, MAD, and FE Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of FM101 in Healthy Volunteers (NCT03879928) | Future Medicine | 2019-01-08 |
| The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition (NCT03738449) | Chong Kun Dang Pharmaceutical | 2019-01-08 |
| Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors (NCT03891706) | Guangzhou FineImmune Biotechnology Co., LTD. | 2019-01-08 |
| Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals (NCT03816878) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-01-08 |
| A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma (NCT03751293) | Hebei Yanda Ludaopei Hospital | 2019-01-08 |
| Wound Healing Endpoint and Recurrence (NCT02577120) | Sashwati Roy | 2019-01-08 |
| An Interaction Study of LY3200882 in Healthy Participants (NCT03792139) | Eli Lilly and Company | 2019-01-08 |
| Hyperhidrosis in Patients With Amputations-Botox (NCT03236012) | University of Utah | 2019-01-08 |
| Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma (NCT03696212) | Arrys Therapeutics | 2019-01-08 |
| A Shedding Study of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF) Vaccine in Adults (NCT03795441) | Janssen Vaccines & Prevention B.V. | 2019-01-07 |
| A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies (NCT03834662) | Bristol-Myers Squibb | 2019-01-07 |
| Targeting the Tumor Microenvironment in R/M SCCHN (NCT03844763) | Gruppo Oncologico del Nord-Ovest | 2019-01-07 |
| A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With Obesity (NCT03787225) | Novo Nordisk A/S | 2019-01-07 |
| Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer (NCT03738228) | National Cancer Institute (NCI) | 2019-01-07 |
| Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer (NCT03798639) | Claire Verschraegen | 2019-01-07 |
| Clinical Study to Evaluate Blood Concentrations of PF-06700841 After Oral Dose as Different Formulations (NCT03765554) | Pfizer | 2019-01-07 |
| Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media (NCT03766373) | Novus Therapeutics, Inc | 2019-01-07 |
| A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study (NCT03844256) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2019-01-07 |
| Evaluation the Pharmacokinetics,Safety,Tolerability of Single Intravitreal Injection RC28-E in Subjects With Wet Age-Related Macular Degeneration (NCT03777254) | RemeGen Co., Ltd. | 2019-01-07 |
| RA Effect on Cell Surface Molecules in Vivo (NCT03753867) | Ottawa Hospital Research Institute | 2019-01-07 |
| A Study of Multiple Doses of ALXN2050 in Healthy Adults (NCT05047484) | Alexion Pharmaceuticals, Inc. | 2019-01-07 |
| Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer (NCT03733210) | Andrei Iagaru | 2019-01-07 |
| Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients (NCT03747224) | Arrowhead Pharmaceuticals | 2019-01-07 |
| Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1 (NCT03560323) | The University of Texas Health Science Center at San Antonio | 2019-01-07 |
| Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (NCT03042143) | Belfast Health and Social Care Trust | 2019-01-07 |
| Rogaratinib (BAY1163877) in Chinese Patients (NCT03788603) | Bayer | 2019-01-07 |
| A Study Evaluating the Mass Balance of [14C]HSK3486 Emulsion Injection in Healthy Adults. (NCT03751956) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2019-01-06 |
| Sonodynamic Therapy in the Treatment of Carotid Atherosclerosis (NCT03871725) | First Affiliated Hospital of Harbin Medical University | 2019-01-05 |
| Safety Observation on hESC Derived MSC Like Cell for the Meniscus Injury (NCT03839238) | Tongji Hospital | 2019-01-04 |
| A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus (NCT03916640) | Adocia | 2019-01-04 |
| A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02 (NCT03776539) | Eloxx Pharmaceuticals, Inc. | 2019-01-04 |
| The Effects of AMPC in the Treatments of Refractory or Relapsed AML (NCT03825146) | Lai Corporation Pty. Ltd. | 2019-01-04 |
| rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide (NCT03687957) | Washington University School of Medicine | 2019-01-04 |
| A Study to Assess the Effect of Seltorexant Compared to Placebo on Respiration During Sleep in Adult Participants With Obstructive Sleep Apnea (NCT03796026) | Janssen Research & Development, LLC | 2019-01-04 |
| A Blood Stem Cell Transplant for Sickle Cell Disease (NCT03249831) | City of Hope Medical Center | 2019-01-04 |
| LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma (NCT03773107) | Wake Forest University Health Sciences | 2019-01-03 |
| Pharmacokinetics of Oral Hydroxyurea Solution (NCT03763656) | Nova Laboratories Limited | 2019-01-03 |
| 18F-ASIS PET/CT Imaging of Tissue Factor Expression In Patients With Primary and Metastastic Cancer (NCT03790423) | Rigshospitalet, Denmark | 2019-01-03 |
| Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) (NCT03813940) | Xiamen University | 2019-01-03 |
| TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer (NCT03720431) | PharmAbcine | 2019-01-03 |
| Phase I Study of Hemay102 in Patients With Advanced Solid Tumors (NCT03982303) | Tianjin Hemay Oncology Pharmaceutical Co., Ltd | 2019-01-03 |
| Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients (NCT03823989) | Lipomedix Pharmaceuticals Inc. | 2019-01-03 |
| A Study of PTC923 (CNSA-001) in Primary Tetrahydrobiopterin (BH4) Deficient Participants With Hyperphenylalaninemia (NCT03519711) | PTC Therapeutics | 2019-01-03 |
| A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects (NCT03814200) | Viatris Innovation GmbH | 2019-01-03 |
| Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects (NCT03820414) | Curevo Inc | 2019-01-03 |
| Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer (NCT03649321) | University of Texas Southwestern Medical Center | 2019-01-03 |
| A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors (NCT03871348) | Sanofi | 2019-01-03 |
| Study Evaluating the Effect of Food on the Pharmacokinetics of Palovarotene and the Effect of Palovarotene on the Pharmacokinetics of the CYP3A4 Substrate Midazolam in Two Cohorts of Healthy Adult Subjects (NCT04829773) | Clementia Pharmaceuticals Inc. | 2019-01-03 |
| Effect of Digital Cognitive Training on the Functionality of Older Adults With Mild Cognitive Impairment (MCI) (NCT03911765) | Universidade Federal do Rio de Janeiro | 2019-01-02 |
| Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure (NCT03758625) | Sharon Riddler | 2019-01-02 |
| Senl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic Leukemia (NCT03840317) | Hebei Senlang Biotechnology Inc., Ltd. | 2019-01-02 |
| Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer (NCT03518320) | Taris Biomedical LLC | 2019-01-02 |
| A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors (NCT03717415) | Deciphera Pharmaceuticals, LLC | 2019-01-02 |
| Safety of Expanded Haploidentical Natural Killer Cells for Leukemia (NCT04327037) | Belarusian Research Center for Pediatric Oncology, Hematology and Immunology | 2019-01-02 |
| Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers (NCT03851341) | GL Pharm Tech Corporation | 2019-01-02 |
| CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy (NCT03851237) | Washington University School of Medicine | 2019-01-02 |
| Psilocybin for Treatment of Obsessive Compulsive Disorder (NCT03300947) | University of Arizona | 2019-01-02 |
| Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir (NCT03670355) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-01-02 |
| Breathe Anew for Lung Cancer Survivorship (NCT03773380) | St. Joseph's Healthcare Hamilton | 2019-01-02 |
| Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children (NCT03868852) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2019-01-01 |
| Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia (NCT05631444) | Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle | 2019-01-01 |
| Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis (NCT03831438) | Bristol-Myers Squibb | 2019-01-01 |
| Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata (NCT05600673) | Ahmed Hassan Nouh MD | 2019-01-01 |
| Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I (NCT03882840) | Second Affiliated Hospital of Guangzhou Medical University | 2019-01-01 |
| A Study to Evaluate the Safety and Efficacy of BOL-DP-o-08 in Patients With Endometriosis Syndrome. (NCT04174911) | Breath of Life International Pharma Ltd | 2019-01-01 |
| Low Dose Ruxolitinib in Combination With Methylprednisolone (NCT04397367) | Chinese PLA General Hospital | 2019-01-01 |